Page last updated: 2024-11-04

rolipram and Irritable Bowel Syndrome

rolipram has been researched along with Irritable Bowel Syndrome in 2 studies

Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.

Research Excerpts

ExcerptRelevanceReference
"For roflumilast, ID(50)s were 24."1.35Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice. ( Barone, FC; Barton, ME; Kikkawa, H; Kinoshita, M; Kuratani, K; Legos, JJ; Shimamura, M; White, RF, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yuan, F1
Ren, H1
Tan, W1
Wang, Y1
Luo, H1
Barone, FC1
Barton, ME1
White, RF1
Legos, JJ1
Kikkawa, H1
Shimamura, M1
Kuratani, K1
Kinoshita, M1

Other Studies

2 other studies available for rolipram and Irritable Bowel Syndrome

ArticleYear
Effect of phosphodiesterase-4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model.
    Neurogastroenterology and motility, 2022, Volume: 34, Issue:7

    Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Inhibitors; Irritable Bowe

2022
Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice.
    Pharmacology, 2008, Volume: 81, Issue:1

    Topics: Aminopyridines; Animals; Antidiarrheals; Benzamides; Cold Temperature; Cyclopropanes; Defecation; Ga

2008